Connor, Clark & Lunn Investment Management Ltd. - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 45 filers reported holding LUMOS PHARMA INC in Q2 2020. The put-call ratio across all filers is 5.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q3 2022$295,000
+14.8%
33,3670.0%0.00%0.0%
Q2 2022$257,000
-18.4%
33,3670.0%0.00%0.0%
Q1 2022$315,000
+35.8%
33,367
-0.2%
0.00%
+100.0%
Q4 2021$232,000
-27.0%
33,4270.0%0.00%
-50.0%
Q3 2021$318,000
+0.3%
33,427
+4.7%
0.00%0.0%
Q2 2021$317,000
-18.7%
31,938
-4.1%
0.00%0.0%
Q1 2021$390,000
-65.1%
33,293
+6.5%
0.00%
-71.4%
Q4 2020$1,116,000
+152.5%
31,251
-2.3%
0.01%
+133.3%
Q3 2020$442,000
-26.6%
31,978
-12.5%
0.00%
-25.0%
Q2 2020$602,000
+91.1%
36,531
-1.3%
0.00%
+33.3%
Q1 2020$315,00037,0300.00%
Other shareholders
LUMOS PHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Acuitas Investments, LLC 153,867$507,7610.30%
Lion Point Capital, LP 78,351$258,5580.12%
Minerva Advisors LLC 26,549$840.06%
Wealth Advisors of Iowa, LLC 11,699$38,6060.03%
Marquette Asset Management, LLC 31,088$102,5910.02%
Greenwich Wealth Management LLC 49,002$1620.02%
Key FInancial Inc 10,927$36,0590.01%
Paladin Advisory Group, LLC 4,387$14,4770.01%
Blackstone Inc. 468,145$1,544,8790.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,643$157,2220.00%
View complete list of LUMOS PHARMA INC shareholders